https://www.selleckchem.com/pr....oducts/bms-986020.ht
5% vs. 24.8%, P 0.01) and having more difficulty sleeping (56.5% vs. 24.8%, P 0.01) than of the patients in the NDOD group (P 0.01). The groups did not differ in terms of impairment of walking capability, anxiety, stress, or depression (P 0.05). A higher proportion of patients in the DOD group reported being sadder and having greater difficulty sleeping compared to the NDOD group during the COVID-19 pandemic. A higher proportion of patients in the DOD group reported being sadder and having greater difficulty sleepin
Like
Comment
Share
